Literature DB >> 33035445

Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy.

Adam S Darwich1, Thomas M Polasek2,3,4, Jeffrey K Aronson5, Kayode Ogungbenro6, Daniel F B Wright7, Brahim Achour6, Jean-Luc Reny8,9, Youssef Daali8, Birgit Eiermann10, Jack Cook11, Lawrence Lesko12, Andrew J McLachlan13, Amin Rostami-Hodjegan4,6.   

Abstract

Model-informed precision dosing (MIPD) has become synonymous with modern approaches for individualizing drug therapy, in which the characteristics of each patient are considered as opposed to applying a one-size-fits-all alternative. This review provides a brief account of the current knowledge, practices, and opinions on MIPD while defining an achievable vision for MIPD in clinical care based on available evidence. We begin with a historical perspective on variability in dose requirements and then discuss technical aspects of MIPD, including the need for clinical decision support tools, practical validation, and implementation of MIPD in health care. We also discuss novel ways to characterize patient variability beyond the common perceptions of genetic control. Finally, we address current debates on MIPD from the perspectives of the new drug development, health economics, and drug regulations.

Entities:  

Keywords:  MIPD; clinical decision support systems; electronic health records; individualized dosing; model-informed precision dosing; pharmacokinetic/pharmacodynamic modeling; systems pharmacology

Year:  2020        PMID: 33035445     DOI: 10.1146/annurev-pharmtox-033020-113257

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  14 in total

Review 1.  The Use of Physiologically Based Pharmacokinetic Analyses-in Biopharmaceutics Applications -Regulatory and Industry Perspectives.

Authors:  Om Anand; Xavier J H Pepin; Vidula Kolhatkar; Paul Seo
Journal:  Pharm Res       Date:  2022-05-18       Impact factor: 4.580

Review 2.  Recent advances in the ontogeny of drug disposition.

Authors:  Brian D Chapron; Alenka Chapron; J Steven Leeder
Journal:  Br J Clin Pharmacol       Date:  2021-04-15       Impact factor: 3.716

3.  Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics.

Authors:  Camille Lenoir; Amine Niederer; Victoria Rollason; Jules Alexandre Desmeules; Youssef Daali; Caroline Flora Samer
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-11-17

Review 4.  Model-Informed Precision Dosing of Antibiotics in Osteoarticular Infections.

Authors:  Lingling Liu; Jin Wang; Huan Zhang; Mengli Chen; Yun Cai
Journal:  Infect Drug Resist       Date:  2022-01-11       Impact factor: 4.003

5.  Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of Drugs.

Authors:  Youssef Daali; Amin Rostami-Hodjegan; Caroline F Samer
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810

Review 6.  Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?

Authors:  M Y Eileen C van der Stoep; Lisa V E Oostenbrink; Robbert G M Bredius; Dirk Jan A R Moes; Henk-Jan Guchelaar; Juliette Zwaveling; Arjan C Lankester
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

Review 7.  Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.

Authors:  Kazuaki Matsumoto; Kazutaka Oda; Kensuke Shoji; Yuki Hanai; Yoshiko Takahashi; Satoshi Fujii; Yukihiro Hamada; Toshimi Kimura; Toshihiko Mayumi; Takashi Ueda; Kazuhiko Nakajima; Yoshio Takesue
Journal:  Pharmaceutics       Date:  2022-02-23       Impact factor: 6.321

8.  Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters.

Authors:  Brahim Achour; Zubida M Al-Majdoub; Agnieszka Grybos-Gajniak; Kristi Lea; Peter Kilford; Mian Zhang; David Knight; Jill Barber; Jeoffrey Schageman; Amin Rostami-Hodjegan
Journal:  Clin Pharmacol Ther       Date:  2020-11-25       Impact factor: 6.903

9.  Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats.

Authors:  Daniel Scotcher; Nicola Melillo; Sirisha Tadimalla; Adam S Darwich; Sabina Ziemian; Kayode Ogungbenro; Gunnar Schütz; Steven Sourbron; Aleksandra Galetin
Journal:  Mol Pharm       Date:  2021-07-20       Impact factor: 4.939

10.  A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors.

Authors:  Jasmine H Hughes; Ron J Keizer
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.